Evaluation of Resorcinarene Trimer Methanesulfonate Aggregation in the Presence of Inorganic Salts and Biomolecules in Aqueous Solutions Using UV–vis Spectroscopy and Electrophoresis Authors: Yurii Shepelytskyi, Vira Grynko, Aiden Lehto, Viktoriia Batarchuk, Guillem Dayer, Yieun Kim, Mateo Wolfe, Gianna M Derrenbacher, Tiffany Kha, Stephen D Kinrade, Carson L Hasselbrink, Mitchell S Albert Published: 2026 ABSTRACT AbstractHyperpolarized (HP) xenon‐129 (129Xe) chemical exchange saturation transfer (HyperCEST) provides the opportunity to perform high‐sensitivity molecular magnetic resonance imaging (MRI) due to superior signal enhancement. One of the most recently discovered candidates for future development of HyperCEST‐active biosensors, resorcinarene trimer methanesulfonate (R3‐Noria‐MeSO3H), possesses unique complex molecular dynamics resulting in its aggregation around metal cations. To study and understand this behavior of R3‐Noria‐MeSO3H and its potential interaction with large biological molecules, we conducted time series of UV–vis spectroscopies of different R3‐Noria‐MeSO3H concentrations in deionized water, phosphate buffer saline, saline, solutions of potassium chloride, choline, and bovine serum albumin (BSA). For the first time, we have acquired R3‐Noria‐MeSO3H UV–vis spectra and identified the origin of all absorption bands. Our data suggested that Na+ promoted R3‐Noria‐MeSO3H aggregation the most, while choline hinders it, albeit did not stop it completely. The absorption bands around 353 and 497 nm are the most indicative of the aggregation process and, therefore, may be utilized in future studies of R3‐Noria‐MeSO3H molecular dynamics. Furthermore, using UV–vis spectroscopy and electrophoretic analysis, we discovered rapid aggregation of R3‐Noria‐MeSO3H around BSA, forming supramolecular assemblies that persist as dynamic but macroscopically stable populations.Keywords: BSA, choline, HyperCEST, R3‐Noria‐methanesulfonate, UV–vis Introduction Molecular imaging has emerged as a critical branch of diagnostic imaging, especially with the increasing adoption of personalized medicine in routine medical care [1]. The advantages of molecular imaging are of paramount importance for precision oncology [1, 2], early detection of neurodegenerative diseases [3, 4], and detection and evaluation of inflammation [5, 6]. While magnetic resonance imaging (MRI) is desirable medical imaging modality for conducting molecular imaging due to its superior spatial resolution and its reliance on radio waves instead of ionizing radiation, conventional MRI performs poorly in molecular imaging settings [7]. The main fundamental challenge of MRI is low sensitivity [8, 9], which substantially limits its potential in the molecular imaging field. Hyperpolarized (HP) xenon‐129 (129Xe) MRI offers up to five orders of magnitude (105) signal enhancement [10], making this technology an attractive alternative for molecular imaging purposes. This outstanding signal boost, alongside 129Xe's ability to naturally dissolve in pulmonary blood and biodistribute across the body and its relatively long relaxation times [11, 12, 13], allowed implementation of HP 129Xe MRI for functional imaging of highly perfused organs such as the lungs [14, 15, 16], brain [17, 18, 19, 20], and kidneys [21, 22]. It is possible, however, to further increase the sensitivity of the HP 129Xe MRI. A key technique is hyperpolarized chemical exchange saturation transfer (HyperCEST), which relies on the reversible binding of HP 129Xe to supramolecular cages that encapsulate the gas [23, 24]. The interaction of HP 129Xe with the supramolecular cage alters its chemical shift, resulting in a distinct Larmor frequency. Application of depolarizing radiofrequency (RF) pulses at this frequency destroys the HP signal within the cage. Subsequent exchange between depolarized 129Xe atoms and the polarized dissolved 129Xe pool generates a detectable signal void around the cage, creating a highly sensitive contrast mechanism. HyperCEST effect amplifies HP 129Xe MRI sensitivity up to 109 times, paving the way for HP 129Xe MRI into the realm of molecular imaging [25, 26]. The macrocycles possessing strong HyperCEST effect can be further functionalized with disease‐specific linkers, enabling their use as molecular biosensors for diagnostic imaging. Over the past two decades, various supramolecular cages, such as cucurbit[6]uril [25, 26, 27, 28, 29], cryptophane‐A [30, 31, 32, 33], pillar[5]arene [34, 35], metal–organic complexes [36, 37, 38, 39], and gas vesicles [40, 41], have been explored for HyperCEST imaging. However, many exhibit drawbacks, including low HyperCEST contrast, complex synthesis, and challenges in functionalization. Recently, our research group reported a novel supramolecular host, resorcinarene trimer methanesulfonate (R3‐Noria‐MeSO3H) [42]. While this macrocycle demonstrated a superior HyperCEST effect, complex aggregation dynamics of R3‐Noria‐MeSO3H in aqueous solutions was observed as well and was corroborated by dynamic light scattering. Interestingly, the R3‐Noria‐MeSO3H aggregation depended strongly on the presence of inorganic salts, resulting in different sizes of aggregates. In order to translate R3‐Noria‐MeSO3H contrast agent further to in vivo HP 129Xe molecular imaging studies, it is of utmost importance to understand its aggregation and the effect of other molecules on it. To further elucidate R3‐Noria‐MeSO3H aggregation in aqueous solutions and its interaction with biological molecules, the present study is focused on the evaluation of R3‐Noria‐MeSO3H time evolution behavior using UV–vis spectroscopy. Implementing UV–vis spectroscopy, we evaluate the effects of biological molecules, such as choline and bovine serum albumin (BSA), as well as inorganic cations concentration and size, on R3‐Noria‐MeSO3H aggregation. For the first time, we have acquired R3‐Noria‐MeSO3H UV–vis spectra and identified the origin of its peaks. Furthermore, based on the 5‐day evolution of the UV–vis spectra, we were able to hypothesize the aggregation mechanism of R3‐Noria‐MeSO3H in the presence of inorganic cations. Interestingly, we observed that although R3‐Noria‐MeSO3H aggregates around BSA, choline slows down R3‐Noria‐MeSO3H aggregation slightly. In addition, by repeating the UV–vis experiments following the addition of AmberChrom ion exchange resin, we observed a pH‐dependent blueshift of the UV–vis spectrum and obtained confirmation of nonreversibility of R3‐Noria‐MeSO3H aggregation around Na+ cations, providing a valuable insight for future biosensor development. The present work provides insights into the molecular dynamics of R3‐Noria‐MeSO3H and sets the stage for further development of R3‐Noria‐MeSO3H‐based molecular imaging agents. Experimental Section Materials NaCl (≥99%), KCl (≥99%), choline chloride (≥98%), phosphate‐buffered saline (PBS) (pH 7.4), AmberChrom 50WX8 ion exchange resin (hydrogen form, 100–200 mesh), and BSA (≥96%) were purchased from Sigma–Aldrich. Synthesis of Resorcinarene Trimer (R3) A 100 mL round‐bottomed flask was charged with resorcinol (11.0 g, 100 mmol), ethanol (22 mL), and glutaraldehyde (1,5‐pentanedial, 50% in H2O) (5.0 g, 25 mmol). Once the solids were dissolved, concentrated (conc.) hydrochloric (HCl) acid (15 mL) was added slowly, and the reaction mixture was refluxed for 72 h. The reaction mixture was cooled to room temperature and poured into methanol (125 mL). The suspension was centrifuged (5000 rpm, 10.0 min) and the supernatant was discarded. The solid was washed with diethyl ether and filtered through a coarse glass‐fritted filter. The yellow powder was left to dry on the filter. 6.92 g of the crude trimer was recovered. The crude trimer was dissolved completely in dimethyl sulfoxide (175 mL). Then methanol (200 mL) was added and stirred until a pale‐yellow precipitate appeared. The suspension was centrifuged (5000 rpm, 5.0 min). The supernatant was decanted off and the solid was washed with diethyl ether. The solid was then filtered over a medium glass‐fritted filter and left to dry on the filter. 2.41 g of pure trimer was recovered as a pale‐yellow solid (34% yield). Synthesis of R3‐Noria‐MeSO3H Pure R3S macrocycle (341 mg, 0.2 mmol) and sodium sulfite (Na2SO3, 378 mg, 3.0 mmol) were dissolved in water (10 mL) in a 25 mL round‐bottom flask. Formaldehyde (37% in H2O, 230 µL, 3.0 mmol) was added, and the mixture was heated for 24 h at 95°C. The solution was cooled on ice and neutralized to pH = 7 with 1.0 N HCl. The solution was poured on chilled acetone (150 mL) and filtered through a medium glass‐fritted filter and washed with acetone (50 mL). The red solid was left to dry and 572 mg was collected (92% yield). Sample Preparation The concentrations of R3‐Noria‐MeSO3H used for the aggregation studies were consistent with those previously reported and included 1000, 500, 250, 100, 10, 5, and 1 µM. The lower concentrations were obtained via a series of dilutions of the 1000 μM stock solution. The solvent panel utilized for the studies consisted of deionized water (DI H2O), PBS, saline (154 mM NaCl in DI H2O), and 154 mM KCl in DI H2O. Additionally, solutions containing biological molecules, such as 154 mM choline chloride in DI H2O and 100 µM bovine serum albumin (BSA) in PBS, were prepared to assess the aggregation behavior of R3‐Noria‐MeSO3H. BSA closely mimics human serum albumin, allowing assessment of binding, stability, and aggregation of R3‐Noria‐MeSO3H. Its well‐characterized, safe, and cost‐effective nature makes it ideal for initial testing before advancing to complex models. To investigate the impact of varying salt concentrations, NaCl solutions at 308, 462, and 616 mM were prepared in DI H2O. Additionally, a separate set of choline chloride solutions with the same concentrations was prepared. In order to evaluate the reversibility of the R3‐Noria‐MeSO3H aggregation, 132 mg of wet AmberChrom 50WX8 Ion Exchange resin was added per 1 mL of 0.1 mM, 0.25 mM, 0.5 mM, and 1 mM R3‐Noria‐MeSO3H solution in saline. Since the addition of the resin significantly reduced the pH of the solution, a separate set of experiments was repeated with the same R3‐Noria‐MeSO3H concentrations dissolved in 0.75 M tris(hydroxymethyl)aminomethane (tris) buffer (pH = 9.05) to distinguish the effect of resin from the effect of pH reduction. The 5 mL of R3‐Noria‐MeSO3H solutions was sampled at 24, 48, and 72 h time, and the resin was added and vigorously agitated for ∼3 min. Next, UV–vis spectra were acquired. UV–vis Spectroscopy UV–vis spectroscopy data were collected over a 5‐day period using a Cary 3500 Compact UV–vis spectrophotometer (Agilent Technologies, Santa Clara, CA, USA). The reversibility of R3‐Noria‐MeSO3H aggregation was conducted using a Cary 60 UV–vis spectrometer (Agilent Technologies, Santa Clara, CA, USA). The first measurement was performed within 10 min of mixing the solutions, with subsequent measurements taken at 24, 48, 72, and 96 h. Data recorded using the Cary UV Workstation software were further processed and analyzed using OriginPro 2022b (OriginLab Corp., USA). Polyacrylamide Gel Electrophoresis Polyacrylamide gel electrophoresis was employed in two complementary modes to assess the structural integrity of BSA and to probe its potential interaction with R3‐Noria‐MeSO3H. Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE, 10%) was carried out on BSA alone to verify its molecular weight and purity under denaturing conditions. Samples were prepared in 1x SDS sample buffer, and 10 µL of BSA in PBS at concentrations of 250, 100, 50, and 10 µM were loaded per lane onto a gel. Samples were electrophoresed for 1.5 h at 120 V at room temperature. Native polyacrylamide gel electrophoresis (native‐PAGE, 10%) was employed to preserve the tertiary structure and noncovalent interactions of proteins, thereby allowing the detection of possible interactions between BSA and R3‐Noria‐MeSO3H. BSA was prepared at a fixed concentration of 100 µM in PBS and incubated with R3S at final concentrations of 1000 µM, 500, 250, 100, 10, 5, and 1 µM in the solution. Electrophoresis was carried out at 4 C and 80 V for 6 h to maintain protein conformation and minimize thermal denaturation. Proteins were visualized using Blue‐Silver Coomassie staining, as described by Candiano et al. [43]. All electrophoresis experiments were performed using standard Bio‐Rad equipment (Mini‐PROTEAN Tetra Cell system). Results and Discussion R3 and R3‐Noria‐MeSO3H Synthesis The successful synthesis of R3 macrocycle and its structure were confirmed using 1H NMR (400 MHz, DMSO‐d6) {δ 9.40 – 8.88 (m, 24H), 7.38 – 6.99 (m, 12H), 6.21 – 6.05 (m, 12H), 4.12 (d, J = 12.6 Hz, 12H), 2.71 (s, 11H), 1.90 (s, 12H), 1.16 – 0.94 (m, 12H)}, 13C NMR (101 MHz, DMSO‐d6) δ 151.5, 151.5, 124.7, 122.8, 103.4, 102.4, 35.6, 33.8. LRMS (MALDI) m/z: [M + Na]+ Calc. for C102H96O24Na: 1727.63, Found: 1727.63 (Figures S1 and S2, Supporting Information), infrared spectroscopy (IR) (Figure S3, Supporting Information), and thermogravimetric analysis (TGA) (Figure S4, Supporting Information). Similarly, the successful synthesis of R3‐Noria‐MeSO3H and its structure were confirmed using 1H NMR (400 MHz, D2O) δ 7.37 – 7.09 (m, 12H), 4.33 (d, J = 12.5 Hz, 12H), 4.13 (s, 24H), 2.91 (s, 12H), 1.91 (s, 12H), 1.49 – 1.14 (m, 12H) (Figure S5, Supporting Information), 13C{1H} NMR (101 MHz, D2O) δ 156.8, 155.6, 126.4, 123.1, 121.1, 120.0, 108.9, 107.5, 48.2, 36.5, 34.8. HRMS (ESI‐TOF) Calc. for C114H108O60S12 −12 [M]−12: 235.0232, Found: 235.1008 (Figure S6, Supporting Information), IR (Figure S7, Supporting Information), and TGA (Figure S8, Supporting Information). R3‐Noria‐MeSO3H UV–vis Spectrum Analysis and Peak Identification The 100 µM R3‐Noria‐MeSO3H spectrum acquired in DI H2O is shown in Figure 1. The spectrum consists of five well‐distinguished peaks. The first and second peaks are located at 223 and 291 nm, respectively, and can be attributed to the π → π* transition in the resorcinol ring based on the previous work of Ezike T.C. et al. [44]. Indeed, the observed absorption bands’ positions and shape are in good agreement with previously reported. While the other peaks in the spectrum observed at 317, 353, and 497 nm do not occur in the known resorcinol spectra, R3S‐Noria‐MeSO3H lacks π‐electrons in any other part of the molecule and, therefore, those parts are quite unlikely to produce any significant UV–vis light absorption. Although sulfonic acid on its own lacks π‐electrons, it can affect the π‐electron system of aromatic rings due to its electron‐withdrawing properties. Therefore, the peaks observed at 317 and 353 nm can be attributed to the conjugation effect between the benzene ring and the autochrome sulfonic acid groups. The final peak occurs in the visible light region at 497 nm. This absorption band becomes noticeable for the 100 μM concentration and gets more prominent at higher concentrations. This increase in the absorption band with R3S‐Noria‐MeSO3H concentration may be indicative of the aggregation dynamic of the supramolecular cage, previously noted for the higher concentrations. Furthermore, such low energy of the absorbed light is indicative of a potential n → π* transition. Therefore, the origin of the 497 nm peak can be attributed to either the electron transition of the lone pair on the oxygens or to the existence of the free electron transitions in R3S‐Noria‐MeSO3H aggregates. A representative UV–vis spectrum of 100 μM R3‐Noria‐MeSO3H in DI H2O (A). The red dashed lines indicate UV absorption band characteristic of π → π* transition of resorcinol, whereas the blue lines show the soft UV absorption peaks unique to R3‐Noria‐MeSO3H and induced by electronegativity of –SO3H group. The magenta dashed lines show the green light absorption induced by n → π* transition in R3‐Noria‐MeSO3H (B) due to transition of lone pair on the oxygens of deprotonated sulfonic acid group. Since the main aggregation mechanism was proposed through electrostatic attraction between deprotonated sulfonates and metal cations, the peak at 497 nm is expected to be in strong positive correlation with the aggregate size, considering two plausible hypotheses of its origin. The R3‐Noria‐MeSO3H UV–vis spectrum looked similar in all solutions, except the BSA solution. Indeed, none of the salts has the π energy levels; therefore, they will not be visible on the UV–vis spectrum. 1 μM concentration spectra showed only 223 and 291 nm peaks due to the overall low concentration of the macrocycle. An increase in concentration up to 5 and 10 μM resulted in the appearance of the 317 nm peak in solutions with salts. All five peaks were present in the spectrum for concentrations above 10 μM; however, the peak position for lower energy bands varied slightly depending on the solution. For the consistency of further discussion, the peaks will be referenced as they appear in the DI H2O spectrum. The measured UV–vis absorption peak positions are included in Table ST1, Supporting Information. The Time Evolution of UV–vis Spectra The time evolution of the peaks was similar for different concentration spectra within the same solvent. There was no noticeable change, neither in absorption intensity nor in the peak position, for the 223 nm band. The time evolution of absorption spectra for 100 μM samples is shown in Figure 2. The peak at 291 nm increased in intensity steadily and demonstrated a hypsochromic shift down to 287 nm for R3‐Noria‐MeSO3H in DI H2O over the course of 5 days. A similar dynamic was observed for saline samples; however, the increase and shift of the peak happened rapidly between the first and the second day, with significantly slower changes in the absorption over subsequent days. In PBS, the 291‐band increased in intensity slowly over time, albeit no shift of the peak was observed (Figure 2B). In KCl, the absorption intensity dropped over the first day; however, it increased over the next 4 days (Figure 2F). Interestingly, the peak dynamic changed once R3‐Noria‐MeSO3H was introduced to choline. The 297 peak intensity decreased steadily over the course of the experiment duration (Figure 2D). The gradual peak shift into shorter wavelengths was still observed down to 294 nm. This absorption change could be explained by the formation of ion pairs between deprotonated sulfonate and the choline quaternary ammonium group, which stabilizes the negative charge on sulfonate, reducing its electron withdrawing effect. 100 μM R3‐Noria‐MeSO3H UV–vis spectra in DI H2O (A), PBS (B), saline (C), choline (D), PBS with 100 μM BSA (E), and KCl (F) acquired over the course of 5 days. There were no substantial changes in the UV–vis spectrum of R3‐Noria‐MeSO3H in the presence of BSA over the course of 5 days (Figure 2E). However, there was a noticeable difference between the spectrum of pure BSA and the BSA in the presence of the R3‐Noria‐MeSO3H ( Figure S9, Supporting Information). Once R3‐Noria‐MeSO3H was introduced to the BSA solution, the hard and soft UV bands became more intense, broader, and changed shape, indicating clear overlapping of R3‐Noria‐MeSO3H UV 223 and 287 nm peaks (R3‐Noria‐MeSO3H in PBS spectra are shown in Figure 2B) with BSA UV absorption peaks. Moreover, the soft UV peaks of the R3‐Noria‐MeSO3H spectrum appeared as shoulders at 322 and 354 nm. Finally, the green light absorption was also observed at 504 nm. The initial change of the BSA spectrum with the addition of the R3‐Noria‐MeSO3H and the lack of change in BSA‐ R3‐Noria‐MeSO3H spectra over the time course of 5 days may indicate rapid R3‐Noria‐MeSO3H aggregation around the BSA protein. This hypothesis was further confirmed with electrophoretic experiments discussed below. The other absorption bands (317, 353, and 497 nm) increased nonlinearly but steadily over the duration of the experiments. The 317 nm band overlapped with the 291 nm peak and became hardly identifiable for solutions in PBS, saline, and KCl due to the absorption increase of the 291 nm band and shift to the shorter wavelength of the 317 nm peak. Similarly, a shift to the shorter wavelength was observed for the 353 nm absorption band. The peak position steadily moved to the shorter wavelength over the course of 5 days for all studied solutions. Interestingly, the absorption peak at 497 did not demonstrate a significant shift over the study duration. The overall hypsochromic peak shifts can be explained by the aggregation of R3S‐Noria‐MeSO3H. The electron orbitals of each individual macrocycle influence each other, resulting in higher energy electron transitions yielding absorption at shorter wavelengths. The time evolution of the 353 and 497 nm peak intensities was evaluated next. The time evolution of the 317 peak was not assessed due to its overlap with the 291 nm peak. The time evolution of the 353 nm absorption band is shown in Figure 3 for concentrations above 100 μM. 353 nm peak demonstrated the strongest and fastest intensity increase in saline compared to any other solvents. R3S‐Noria‐MeSO3H in KCl demonstrates a less rapid increase in apposition intensity over the first 24 h, while it increases gradually toward a similar level over the next 72 h. While the 353 nm peak was less intense for R3S‐Noria‐MeSO3H in DI H2O and PBS, the hyperchromic shift in PBS occurred much more rapidly over the first day compared to DI H2O. Finally, the 353 nm band in solution with choline was found to be much less intense compared to all other solutions, and the hyperchromic effect happened much more slowly and steadily over the time course of the experiment. R3S‐Noria‐MeSO3H 353 nm absorption peak time dynamics in DI H2O (A), PBS (B), saline (C), KCl (D), and choline (E). Similar to the 353 nm absorption band, the R3S‐Noria‐MeSO3H 497 nm absorption peak experienced the strongest nonlinear increase (Figure 4), with the fastest change occurring over the first 24 h. The green light absorption increased in KCl more gradually, while remaining the second strongest compared to the other solutions. While visible light absorption in PBS still occurred faster over the first day compared to DI H2O, the overall intensity increase of the green band is stronger in DI H2O over the course of the experimental timeline. Interestingly, the change of R3S‐Noria‐MeSO3H 497 nm peak in choline is quasilinear and reaches a similar value to R3S‐Noria‐MeSO3H 497 nm peak in PBS. R3S‐Noria‐MeSO3H 497 nm absorption peak time dynamics in DI H2O (A), PBS (B), saline (C), KCl (D), and choline (E). The overall 353 and 497 nm peak dynamics allow us to hypothesize the effect of different cations on R3S‐Noria‐MeSO3H aggregation. Since R3S‐Noria‐MeSO3H aggregation around cations previously was attributed to the Coulomb interaction between the SO3 − group and metal ion, aggregation around ions should reduce the flexibility of the MeSO3 − group, resulting in more efficient conjugation and increasing the UV–vis absorbance caused by corresponding electron transitions. Therefore, our data support that Na+ cations significantly promote R3S‐Noria‐MeSO3H aggregation in the solution. K+ ions seem to be less favorable for R3S‐Noria‐MeSO3H coordination compared to Na+, while still being able to coordinate R3S‐Noria‐MeSO3H. This could be explained by the smaller charge density of K+, resulting in a weaker Coulomb interaction with the R3S‐Noria‐MeSO3H macrocycle. While DI H2O should not have a high number of cations present, the R3S‐Noria‐MeSO3 itself contained some Na+ since Na+ was used as a counterion during the supramolecular synthesis. Therefore, it is safe to assume that aggregation in DI H2O happens via Na+ mediation, albeit with a much lower concentration of Na+. R3S‐Noria‐MeSO3H aggregation in PBS appeared to be slightly hindered. PBS solution contains around 12 mM of strongly negatively charged (−3) phosphates. The presence of the phosphates introduces strong Coulomb repulsion to R3S‐Noria‐MeSO3H, which will diminish its potential to form larger aggregates. In addition, there is a competitive interaction of K+ and Na+ cations with R3S‐Noria‐MeSO3H, which may prevent rapid aggregation, albeit it may potentially result in more complex K+/Na+ mediated aggregates. Lastly, the presence of choline tends to significantly slow down R3S‐Noria‐MeSO3H aggregation during the studied 96‐h time period. The large quaternary amine prevents close packing of the negatively charged R3S‐Noria‐MeSO3H, preventing formation of the large aggregates. Furthermore, choline in general cannot coordinate as many sites as Na+ or K+ can, resulting in local binding to the negatively charged outer parts of R3S‐Noria‐MeSO3H macrocycle, hindering its ability to coordinate with different cations. The observed limited aggregation in choline solution probably originates from R3S‐Noria‐MeSO3H interaction with Na+ counterions. The Effect of Na+ Cations and Choline Concentration on R3S‐Noria‐MeSO3H Spectra To further confirm that Na+ promotes R3S‐Noria‐MeSO3H aggregation while choline hinders it, we evaluated UV–vis spectra of R3S‐Noria‐MeSO3H at different concentrations in the presence of doubled, tripled, and quadrupled amounts of Na+ and choline. The representative spectra of 100 μM R3S‐Noria‐MeSO3H samples in 154, 308, 462, and 616 mM NaCl and choline solutions are shown in Figure 5A,B, respectively. The initial increase of Na+ amount did not result in significant changes in R3S‐Noria‐MeSO3H UV–vis absorption. Further increase of Na+ cations amount resulted in a small intensity increase in the soft UV and visible light absorption. The increase up to 616 mM concentrations of Na ions resulted in a significant increase in the light absorption. Interestingly, there were no observable changes in R3S‐Noria‐MeSO3H spectra associated with the same increase in choline concentrations (Figure 5B). The effect of increase in Na+ and choline concentration on R3S‐Noria‐MeSO3H UV–vis absorption. While the absorption of UV radiation and visible light of 100 μM R3S‐Noria‐MeSO3H increased with Na+ concentration (A), an increase in the amount of choline does not affect the measured R3S‐Noria‐MeSO3H spectra (B). The 353 nm absorption (C) and 497 nm absorption (D) increased quasilinearly with the increase of R3S‐Noria‐MeSO3H concentration for all studied concentrations of Na+. Figure 5C,D show the R3S‐Noria‐MeSO3H 353 and 497 nm absorption changes, respectively, as a function of R3S‐Noria‐MeSO3H concentration and amount of Na+. The UV–vis absorption increased linearly with R3S‐Noria‐MeSO3H concentration in the presence of 154 mM, 308, and 462 mM of Na+ ions. For samples with 616 mM of Na+, a slight nonlinearity appears. There were no significant differences observed for 353 and 497 nm absorption bands between 154 and 308 mM NaCl solutions. However, a further increase of Na+ concentration resulted in a quasilinear increase in light absorbance for all R3S‐Noria‐MeSO3H concentrations above 10 μM. As was previously observed by Shepelytskyi Y. et al [42]., the R3S‐Noria‐MeSO3H aggregate size perfectly correlates with the [NaCl]/[R3S‐Noria‐MeSO3H] ratio. Therefore, an increase in NaCl concentration is supposed to result in linear increase in R3S‐Noria‐MeSO3H particle size. The observed quasilinear increase in 353 and 497 nm peaks indicates the presence of a positive correlation between these absorption band intensities and the R3S‐Noria‐MeSO3H particle size, further supporting the claims that the 497 nm peak originates from R3S‐Noria‐MeSO3H aggregates and provides the insight that aggregation occurs through cation interaction with outer sulfonic acid groups. The complete absence of any significant change in R3S‐Noria‐MeSO3H spectra with an increase in choline concentration further supports the aforementioned hypothesis that the presence of choline hinders R3S‐Noria‐MeSO3H aggregation. An interesting approach for future studies would be to measure the change in R3S‐Noria‐MeSO3H aggregate size in aqueous solutions with different amounts of choline added, as well as at different [Na+]/[choline] ratios. Finally, in order to determine if R3‐Noria‐MeSO3H aggregation around cations is reversible, an ion exchange resin was added to a 0.1, 0.25, 0.5, and 1 mM R3‐Noria‐MeSO3H solution in saline, and UV–vis spectra were recorded. Upon introduction of resin to the solution, the solution color changed to bright yellow, and the pH decreased from 7.1 to approximately 1. The spectral peaks associated with sulfonic acid group experienced a substantial blue shift (Figure S10, Supporting Information). The 497 nm peak shifted down to the 440–442 nm range (Figure S11, Supporting Information). To separate the potential effect of pH change from the effect of Na+ absorption by resin, the experiments were repeated in a tris buffer. The R3‐Noria‐MeSO3H solutions in tris demonstrated pH of 9.4. The addition of AmberChrom resin decreased pH to 8.2. Unlike the saline solution, there was no significant peak shift due to the pH change. The obtained pH dependance of 497 nm peak is shown in Figure S11, Supporting Information. The addition of resin resulted in ∼32% absorbance reduction in 497 nm peaks in saline for all studied concentrations of R3‐Noria‐MeSO3H (Figure S12, Supporting Information). The significant pH reduction resulted in protonation of sulfonate groups yielding disappearance of a single lone electron pair on one oxygen of sulfonic group. Corresponded reduction of absorbance by ∼1/3 indicates that the origin of the 497 nm peak is indeed n→π* transition associated with lone pairs on sulfonates oxygens. The samples in the tris buffer did not show a significant change in the 497 nm peak absorbance after the addition of resin, which is expected since the sulfonate groups remained deprotonated. The peak absorbance of the 497 nm band did not change significantly between samples with resin added at 24, 48, and 72 h. However, R3‐Noria‐MeSO3H solutions in tris demonstrated a similar increase in 353 nm absorbance with time as samples without resin (Figure S13, Supporting Information). It should be mentioned that tris buffer did not contain any Na+ cations. Na+ ions were introduced into the solution during dissolution of R3‐Noria‐MeSO3H, since each molecule has 12 Na+ ions per molecule. Therefore, the time dynamic and potential aggregation in tris should have a similar mechanism as for DI H2O samples. The increase in 353 nm peaks with time still present after addition of AmberChrom resin indicates that R3‐Noria‐MeSO3H aggregation around Na+ is probably irreversible. The conducted experiments with the addition of resin allow us to clarify the origin of the 497 nm peak and attribute it with a high level of confidence to a lone pair electron transition. While originally both 353 and 497 nm bands were potentially indicative of R3‐Noria‐MeSO3H aggregation, the lack of absorbance change in the 497 nm band after the addition of the resin, while the 353 nm band preserves its original dynamics, suggests that the 353 nm band can be further used for R3‐Noria‐MeSO3H aggregation assessment. While the observed lack of R3‐Noria‐MeSO3H aggregation reversibility may be viewed as a potential challenge for further implementation of this macrocycle as a molecular imaging contrast agent and biosensor, it can be easily mitigated and, in practice, may not even present itself as an issue. First and foremost, R3‐Noria‐MeSO3H should undergo further functionalization before it may be implemented for the purposes of molecular imaging. R3‐Noria‐MeSO3H conjugation to a high‐affinity linker, antibody, or nanobody will result in sterically hindered aggregation. Moreover, in the case of R3‐Noria‐MeSO3H conjugation to antibodies, the size of the macrocycle becomes substantially smaller compared to the size of the affinity tag, which may result in the complete absence of aggregation since the Coulomb forces will not be able to significantly affect the molecular dynamics of the antibody. While further studies of R3‐Noria‐MeSO3H aggregation in the presence of different cations are needed, the development of R3‐Noria‐MeSO3H aggregates around heavier ions such as Fe3+, Gd3+, and Co2+ will allow the creation of contrast agents for both conventional and multinuclear MRI, as well as for computed tomography. Finally, while further studies on potential control of R3‐Noria‐MeSO3H aggregation is required, the controlled aggregation may allow the development of R3‐Noria‐MeSO3H for drug delivery purposes. Electrophoretic Analysis of BSA and Its Interaction with R3‐Noria‐MeSO3H SDS–PAGE was used to establish a baseline reference for the electrophoretic behavior of BSA (Sigma–Aldrich, A4737). Under denaturing conditions, sodium dodecyl sulfate disrupts all noncovalent interactions and enforces migration based solely on molecular weight, making this approach particularly valuable for confirming protein identity and assessing purity. As shown in Figure 6, a single prominent band at ∼ 66.5 kDa was consistently detected across all concentrations, matching the expected molecular weight of monomeric BSA. SDS–PAGE analysis of BSA at increasing concentrations (10–250 µM) in PBS. A single prominent band at ∼66.5 kDa, corresponding to monomeric BSA, was consistently observed across all concentrations. Additional faint higher‐molecular‐weight bands represent oligomeric species. Band broadening at higher concentrations (≥250 µM) is attributed to the increase of the mass loaded. The band intensity scaled with protein concentration, confirming correct sample handling and proportional loading. At higher BSA concentrations, the principal band appeared broader and less sharply resolved, most reasonably explained by partial overloading of the gel. Faint additional bands above 100 kDa were detected across all concentrations. These reflect oligomeric forms of BSA present in commercial albumin preparations. Importantly, no evidence of band shifting or new bands was observed, demonstrating that BSA retained its molecular integrity under denaturing conditions and that no covalent modifications occurred during electrophoresis. Because sodium dodecyl sulfate disrupts all supramolecular assemblies, R3‐Noria‐MeSO3H was not included in these assays. Thus, the SDS–PAGE data confirm the integrity of BSA and provide a robust reference for interpreting the more complex patterns observed in native‐PAGE. For native‐PAGE, the solution of the BSA in PBS at 100 µM was incubated with R3‐Noria‐MeSO3H at a range of final concentrations chosen to mirror those employed in the UV–vis spectroscopy experiments. Two separate gels were prepared to accommodate this range (Figure 7). This setup allowed evaluation of all concentrations used in spectroscopy, except for the lowest (1 µM). The 10 µL of each sample was loaded per lane, with empty lanes left between to prevent overspilling. Electrophoresis was performed under nondenaturing conditions at 4°C for 6 h and 80 V. As shown in Figure 6, in the control lane containing only BSA, a sharp, well‐defined band corresponding to the monomer was observed, establishing a baseline reference. Increasing concentrations of R3‐Noria‐MeSO3H produced progressive alterations in the migration profile. At the lowest tested concentrations (5 and 10 µM), the monomeric BSA band remained visible but exhibited slight broadening and faint trailing smears, suggesting limited heterogeneity in binding stoichiometry. At intermediate concentrations (100 and 250 µM), vertical smearing became more pronounced, extending throughout the separation range, and a higher‐molecular‐weight impurity band displayed a clear mobility shift. At the highest concentrations (500 and 1000 µM), the gels were dominated by extensive smearing and diffuse material lingering near the wells, consistent with the formation of very large supramolecular aggregates that were unable to enter the gel matrix efficiently. Native‐PAGE analysis performed with a solution of 100 µM BSA in PBS incubated with R3‐Noria‐MeSO3H at varying final concentrations of R3‐Noria‐MeSO3H in the solution. Figure 6A shows samples at 5, 250, and 1000 µM. Figure 6B includes 10, 100, and 500 µM. Control lanes containing only BSA show a sharp monomeric band, while progressive increases in R3‐Noria‐MeSO3H concentration produce band thickening, vertical smearing, and mobility shifts, particularly in higher‐molecular‐weight species. At the highest concentrations, diffuse staining and material retention near the wells indicate formation of large supramolecular assemblies or partial precipitation. These gel patterns confirm concentration‐dependent, noncovalent interactions between BSA and R3‐Noria‐MeSO3H, consistent with UV–vis spectroscopy evidence of rapid aggregation and the formation of nonspecific supramolecular complexes. These observations confirm that R3‐Noria‐MeSO3H induces concentration‐dependent perturbations in BSA migration under native conditions, with the strongest effects observed in less stable species. The systematic testing of R3‐Noria‐MeSO3H concentrations across two gels aligned with the UV–vis results. Rapid R3‐Noria‐MeSO3H aggregation around protein surfaces yields spectral changes but manifests in native gels as smearing and mobility shifts reflecting the underlying polydispersity and dynamic exchange of the assemblies. Although R3‐Noria‐MeSO3H is much smaller than BSA, its high negative charge density and aromatic macrocyclic structure make it highly interactive with the protein surface. BSA presents multiple cationic residues (lysines, arginines) and hydrophobic pockets that provide docking sites for small molecules. R3‐Noria‐MeSO3H can therefore associate with BSA through electrostatic attraction to positively charged patches and, to a lesser extent, through hydrophobic interactions with aromatic residues. These interactions drive rapid association of R3‐Noria‐MeSO3H with BSA, even at low concentrations. However, the binding remains noncovalent, heterogeneous, and dynamically unstable. Because R3‐Noria‐MeSO3H tends to self‐aggregate in aqueous solution, different BSA molecules could bind variable numbers and sizes of R3‐Noria‐MeSO3H aggregates, producing a polydisperse distribution of complexes. This explains the vertical smearing observed in native‐PAGE, as complexes with different charge‐to‐mass ratios migrate differently and continuously exchange during electrophoresis. The instability is further enhanced by the ionic environment of PBS, where sodium and potassium ions both promote and compete with R3‐Noria‐MeSO3H aggregation, creating constant fluctuations in the complexes. This behavior correlates directly with the UV–vis spectroscopy findings and suggests rapid aggregation of R3‐Noria‐MeSO3H around BSA, forming supramolecular assemblies that persist as dynamic but macroscopically stable populations. Thus, the spectroscopy reflects the initial fast association and stabilization of aggregates, while native‐PAGE reveals their underlying heterogeneity and dynamic exchange, manifested as smears and mobility shifts. Finally, the accumulation of material near the wells at high R3‐Noria‐MeSO3H concentrations is consistent with the formation of very large complexes or partial precipitation, reinforcing the conclusion that BSA–R3‐Noria‐MeSO3H interactions under native conditions are weak, nonspecific, and dominated by polydisperse aggregation, with the most prominent mobility shift observed at the 130 kDa band, which could correspond to a BSA oligomer. Conclusion In the present work, for the first time, we have acquired R3‐Noria‐MeSO3H UV–vis spectra and identified the origin of its peaks. Based on the UV–vis absorption band evolution in the presence of the inorganic salts and BSA, we were able to identify that 353 and 497 nm peaks are the best absorption bands for monitoring R3‐Noria‐MeSO3H aggregation. Among the studied cations, Na+ was promoting macrocycle aggregation the most while choline slowed the aggregation process down. Furthermore, the spectral dynamics of R3‐Noria‐MeSO3H in solutions with BSA suggested rapid aggregation of the macrocycle around the protein. Electrophoretic experiments confirmed that BSA maintains its molecular identity under denaturing conditions, but undergoes pronounced concentration‐dependent mobility changes when incubated with R3‐Noria‐MeSO3H under native conditions. The smearing and shifts observed in native‐PAGE, when considered alongside the UV–vis spectral broadening, provide consistent evidence for rapid, electrostatically driven aggregation of R3‐Noria‐MeSO3H around protein surfaces. These complementary findings highlight that R3‐Noria‐MeSO3H interacts weakly with monomeric BSA but forms polydisperse supramolecular assemblies. Finally, the R3‐Noria‐MeSO3H aggregation was found to be irreversible upon removal of cations from the solution. Overall, the outcomes of this research provide insights into the nature of R3‐Noria‐MeSO3H aggregation processes and interaction with biological molecules, which will be useful in further development of R3‐Noria‐MeSO3H‐based molecular imaging agents. Supporting Information Additional supporting information can be found online in the supporting information section. Funding This work was supported by the Natural Sciences and Engineering Research Council of Canada (RGPIN‐2024‐06603), New Frontiers in Research Fund (NFRFE‐2024‐00747), Mitacs (IT31144), Thunder Bay Regional Health Science Center Seed Funding (RP‐1092). Conflicts of Interest The authors declare no conflicts of interest. Supporting information Supplementary Material Acknowledgments The authors would like to thank Tyson Bouchard, Elizabeth Turubchuk, and Brad Miller for their assistance with UV–vis spectrometer. This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (RGPIN‐2024‐06603), Mathematics of Information Technology and Complex Systems (Mitacs) Accelerate grant (IT31144), New Frontiers in Research Fund (NFRF) Exploration grant (NFRFE‐2024‐00747), and Thunder Bay Regional Health Science Center Seed Funding (RP‐1092). Contributor Information Yurii Shepelytskyi, Email: yshepely@lakeheadu.ca. Mitchell S. Albert, Email: malbert1@lakeheadu.ca. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. References Associated Data Supplementary Materials Supplementary Material Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request.